SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLGM who wrote (76)12/26/2001 9:01:56 AM
From: Arthur Radley   of 1590
 
My apology to all our Canadian friends, but AXCA is a sleeping biotech because they are domiciled in Canada. If they were a US company they would get the proper respect they deserve. Helicide should get FDA approval in 2002 and should get gold standard labeling for h pylori treatment. Just got through reading an article in today's paper about the growing nature of this disease and other gastro diseases. They have a nice niche and growing profits...not something that many biotechs can say....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News